Вклад участника
- 19:08, 20 мая 2024 (разн. | история) . . (+3487) . . Н Costeffectiveness-regarding-empagliflozin-as-opposed-to-every-week-semaglutide-because-addon-treatments-with-regard-to-Diabetes-f (Costeffectiveness-regarding-empagliflozin-as-opposed-to-every-week-semaglutide-because-addon-treatments-with-regard-to-Diabetes-f) (текущая)